Skip to main content

Ameritas Investment Partners, Inc.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1055980 LINCOLN, NE

Position in NBIX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$2,435,740
-$155,919 QoQ
Shares Held
18,489
+1.2% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Ameritas Investment Partners, Inc. holds $15,281,212 across 38 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (15.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
18,489 $2,435,740

All Filings in NBIX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,435,740 18,489
2025-12-31 $2,591,659 18,273
2025-09-30 $2,609,944 18,592
2025-06-30 $2,415,133 19,215
2025-03-31 $2,169,640 19,617
2024-12-31 $2,768,083 20,279
2024-09-30 $2,386,897 20,716
2024-06-30 $2,946,826 21,405
2024-03-31 $3,026,378 21,943
2023-12-31 $2,858,401 21,694
2023-09-30 $2,463,862 21,901
2023-06-30 $2,297,808 24,367
2023-03-31 $2,488,999 24,590
2022-12-31 $2,971,667 24,880
2022-09-30 $2,612,341 24,596
2022-06-30 $2,472,580 25,365
2022-03-31 $2,377,968 25,365
2021-12-31 $2,160,337 25,365
2021-09-30 $2,404,559 25,071
2021-06-30 $2,487,012 25,555
2021-03-31 $2,509,050 25,800